Specialist medicine. One doctor per organ.
It is a service someone performs.
It exists to relieve Conditions accumulate and specialists multiply and The body costs more each year. That is the whole reason it is here: nothing enters this map without a human problem behind it.
It could not exist without Medical science and Hospital system. These are the quiet preconditions — remove any one and the solution stops working.
21 organisations in this map sell it, 21 of them publicly listed.
Its neighbourhood
Everything this entry connects to directly. Click any point to follow it.
The line back to a human being
2 hops from a person at a phase of life. The further a thing sits from the person, the more abstract it looks — and the more it tends to be mistaken for something that came from nowhere.
- SolutionSpecialist medicine
- FrictionConditions accumulate and specialists multiply
- Life phaseLate career
- Rooted inMortality
- Rooted inSafety
Relieves
Requires
Who sells it
| Organisation | Value | Type | Products |
|---|---|---|---|
| Johnson & Johnson | $380B | public · JNJ | pharma, MedTech, talc litigation |
| Roche | $240B | public · ROG | oncology, diagnostics, Alzheimer's blood tests |
| AstraZeneca | $230B | public · AZN | oncology, Farxiga, vaccines |
| Merck | $220B | public · MRK | Gardasil, MMR-II, Keytruda |
| Novartis | $220B | public · NOVN | Entresto, Kisqali, Sandoz spun out |
| Siemens | $200B | public · SIE | industrial automation, rail, smart infrastructure |
| Intuitive Surgical | $180B | public · ISRG | da Vinci surgical robots |
| Vertex Pharmaceuticals | $115B | public · VRTX | cystic fibrosis drugs, Casgevy gene editing, non-opioid pain |
| HCA Healthcare | $90B | public · HCA | hospitals, labor and delivery units, urgent care |
| CSL | $80B | public · CSL | plasma therapies, flu vaccines |
| Regeneron | $65B | public · REGN | Eylea, Dupixent |
| Samsung Biologics | $50B | public · 207940 | biologics contract manufacturing |
| Mindray | $45B | public · 300760 | patient monitors, ultrasound |
| Takeda | $45B | public · TAK | rare disease, vaccines, plasma |
| Daiichi Sankyo | $45B | public · 4568 | Enhertu, oncology ADCs |
| WuXi AppTec | $30B | public · 2359 | contract drug development and manufacturing |
| Philips | $25B | public · PHIA | imaging, sleep and respiratory care, Avent baby bottles and pumps |
| Terumo | $25B | public · 4543 | medical devices, blood management |
| Tempus AI | $12B | public · TEM | genomic testing, AI diagnostics |
| Apollo Hospitals | $12B | public · APOLLOHOSP | hospitals, pharmacies, telehealth |
| DaVita | $10B | public · DVA | dialysis |